Reports for APO-RIVASTIGMINE
Brand name
APO-RIVASTIGMINE
Company Name
APOTEX INC
|
Drug Identification Number
02336715 |
Ingredients
RIVASTIGMINE |
Ingredient Strength
1.5 MG |
ATC Code
N06DA |
ATC Descriptor
ANTI-DEMENTIA DRUGS |
Status
MARKETED
|
Shortage reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|
| APO-RIVASTIGMINE | 100 BTL | Resolved | 2017-09-04 | 2019-10-15 | 20900 |
| APO-RIVASTIGMINE | 100 BTL | Resolved | 2022-11-27 | 2023-03-09 | 175898 |
| APO-RIVASTIGMINE | 100 BTL | Resolved | 2023-07-21 | 2024-01-05 | 199518 |
| APO-RIVASTIGMINE | 100 BTL | Actual shortage | 2024-03-08 | 2024-03-22 | 221729 |
Showing 1 to 4 of 4
Discontinuation reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|
Showing 1 to 0 of 0